Severe strongyloidiasis during interferon plus ribavirin therapy for chronic HCV infection

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 2, 2000, Pages 245-246

  Paraná, Raymundo ^a,c   Portugal, Marcelo ^a   Vitvitski, Ludmila ^b   Cotrim, Helma ^a   Lyra, Luis ^a   Trepo, Christian ^b  

^a Hospital Portugues (Salvador Bahia)   (Brazil)

^b INSERM   (France)

^c NONE   (Brazil)

Author keywords

Hepatitis C virus; Immunosuppression; Ribavirin; Strongyloidiasis

Indexed keywords

ALPHA INTERFERON; ANTHELMINTIC AGENT; CORTICOSTEROID; RIBAVIRIN; TIABENDAZOLE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HEPATITIS C; HUMAN; IMMUNE DEFICIENCY; PRIORITY JOURNAL; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 0034068148     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012020-00019     Document Type: Article

References (8)

1. 1 Zoulim F, Trepo C. Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. J Hepatol 1994; 21:142-144.
2. 2 Patterson JL, Fernandez-Larson R. Molecular mechanisms of action of ribavirin. J Infect Dis 1990; 12:1139-1146.
3. 3 Bodenhaimer HC, Lindsay KL, Davis GL, Thung SN, Seef LB. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology 1997; 26:473-477.
4. 4 Reichard O, Yun ZB, Sonnerborg A, Weiland O. Hepatitis C viral RNA titre in serum prior to, during and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol 1993; 41:99-102.
5. 5 Zoulin F, Haem J, Ahmed S, Chossegros P, Habersetzer F, Chevalier M, et al. Ribavirin monotherapy in patients with chronic hepatitis C. J Viral Hepatitis 1998; 5:193-198.
6. 6 Ning Q, Brown D, Parodo J, Kattral M, Fung L, Liu M, et al. Ribavirin inhibits viral induced macrophage production of tumor necrosis factor, interleukin 1, and procoagulant activity and preserves TH1 cytokine production, but inhibits TH2 cytokine response [Abstract]. Hepatology 1996; 24:355A.
7. 7 Moussali J, Opolon P, Poynard T. Management of hepatitis C. J Viral Hepatitis 1998; 5:73-82.
8. 8 Cruz T, Rebouças G, Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 1966; 275:1093-1096.